OrthoPediatrics Q3 2021 Earnings Report
Key Takeaways
OrthoPediatrics reported a 13% increase in revenue for Q3 2021, reaching $25.1 million compared to $22.2 million in Q3 2020. The company's international revenue saw a significant increase of 118%, while U.S. revenue declined by 1%. Despite challenges from COVID-19, RSV, and hospital staffing shortages, the company reiterated its full-year revenue guidance of $97-$101 million.
Total revenue for Q3 2021 was $25.1 million, a 13% increase year-over-year.
U.S. revenue decreased by 1%, while international revenue increased by 118%.
Worldwide Trauma & Deformity revenue grew 12%, Scoliosis revenue grew 11%, and Sports Medicine/Other revenue grew 46%.
The company helped a record 10,400 children in Q3 2021.
OrthoPediatrics
OrthoPediatrics
OrthoPediatrics Revenue by Segment
OrthoPediatrics Revenue by Geographic Location
Forward Guidance
The Company is maintaining its full year revenue guidance range of $97 to $101 million, representing growth of 36% to 42% over 2020 revenue.
Revenue & Expenses
Visualization of income flow from segment revenue to net income